SMi’s 8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates, interactive workshops and keynote addresses tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.
This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
Join us next February to expand your scientific horizons on emerging concepts in nanoparticle delivery systems, small activating RNA and 3rd generation antisense technology. Plus, we’ll be honing in on under-met areas such as targeted delivery beyond the liver, and offering regulatory guidance on the reporting of clinical data through an exclusive MHRA keynote.
Featured speakers include:
Reasons to attend RNA Therapeutics 2017:
For further details and to register, visit the website at http://www.therapeutics-rna.com/euagenda
22 Feb 2017 @ 08:30 am
23 Feb 2017 @ 05:30 pm
Duration: 1 days, 9 hours
Copthorne Tara Hotel
1 Scarsdale Place
Kensington
United Kingdom
English en